PROCTER & GAMBLE HEALTH | DISHMAN CARBOGEN AMCIS | PROCTER & GAMBLE HEALTH/ DISHMAN CARBOGEN AMCIS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | -23.3 | - | View Chart |
P/BV | x | 10.6 | 0.6 | 1,704.5% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH DISHMAN CARBOGEN AMCIS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
DISHMAN CARBOGEN AMCIS Mar-23 |
PROCTER & GAMBLE HEALTH/ DISHMAN CARBOGEN AMCIS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 201 | 2,664.8% | |
Low | Rs | 3,883 | 80 | 4,850.7% | |
Sales per share (Unadj.) | Rs | 740.7 | 153.9 | 481.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | -1.9 | -7,272.6% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 16.0 | 969.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 370.6 | 120.8% | |
Shares outstanding (eoy) | m | 16.60 | 156.78 | 10.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.9 | 682.8% | |
Avg P/E ratio | x | 33.5 | -74.0 | -45.2% | |
P/CF ratio (eoy) | x | 29.8 | 8.8 | 339.0% | |
Price / Book Value ratio | x | 10.3 | 0.4 | 2,720.7% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 22,059 | 348.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 10,353 | 19.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 24,129 | 51.0% | |
Other income | Rs m | 184 | 278 | 66.2% | |
Total revenues | Rs m | 12,480 | 24,407 | 51.1% | |
Gross profit | Rs m | 3,247 | 2,841 | 114.3% | |
Depreciation | Rs m | 281 | 2,807 | 10.0% | |
Interest | Rs m | 8 | 857 | 0.9% | |
Profit before tax | Rs m | 3,142 | -546 | -575.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -248 | -341.8% | |
Profit after tax | Rs m | 2,295 | -298 | -770.0% | |
Gross profit margin | % | 26.4 | 11.8 | 224.3% | |
Effective tax rate | % | 27.0 | 45.4 | 59.4% | |
Net profit margin | % | 18.7 | -1.2 | -1,511.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 19,184 | 61.1% | |
Current liabilities | Rs m | 6,791 | 17,984 | 37.8% | |
Net working cap to sales | % | 40.0 | 5.0 | 805.1% | |
Current ratio | x | 1.7 | 1.1 | 161.7% | |
Inventory Days | Days | 263 | 71 | 371.9% | |
Debtors Days | Days | 343 | 9 | 3,849.1% | |
Net fixed assets | Rs m | 10,617 | 75,211 | 14.1% | |
Share capital | Rs m | 166 | 314 | 52.9% | |
"Free" reserves | Rs m | 7,265 | 57,783 | 12.6% | |
Net worth | Rs m | 7,431 | 58,097 | 12.8% | |
Long term debt | Rs m | 0 | 10,467 | 0.0% | |
Total assets | Rs m | 22,330 | 94,395 | 23.7% | |
Interest coverage | x | 409.1 | 0.4 | 112,706.3% | |
Debt to equity ratio | x | 0 | 0.2 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.3 | 215.4% | |
Return on assets | % | 10.3 | 0.6 | 1,741.5% | |
Return on equity | % | 30.9 | -0.5 | -6,020.6% | |
Return on capital | % | 42.4 | 0.5 | 9,345.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 3,980 | 36.8% | |
Fx outflow | Rs m | 1,605 | 761 | 210.9% | |
Net fx | Rs m | -140 | 3,219 | -4.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 2,203 | 107.1% | |
From Investments | Rs m | -215 | -4,485 | 4.8% | |
From Financial Activity | Rs m | -985 | 2,497 | -39.4% | |
Net Cashflow | Rs m | 1,160 | 216 | 538.4% |
Indian Promoters | % | 0.0 | 59.3 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 11.1 | 180.6% | |
FIIs | % | 6.2 | 8.7 | 71.7% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 40.7 | 118.4% | |
Shareholders | 56,778 | 50,656 | 112.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | DISHMAN CARBOGEN AMCIS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | -1.97% | 0.45% |
1-Month | -1.15% | 3.94% | 2.55% |
1-Year | 0.73% | 58.90% | 56.14% |
3-Year CAGR | -8.76% | 15.75% | 15.22% |
5-Year CAGR | 4.97% | 0.31% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the DISHMAN CARBOGEN AMCIS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of DISHMAN CARBOGEN AMCIS the stake stands at 59.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of DISHMAN CARBOGEN AMCIS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
DISHMAN CARBOGEN AMCIS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of DISHMAN CARBOGEN AMCIS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.